Evidence map›Paper›PMID 37288179›Full record

ArticleCureus2023

Solitary Extramedullary Plasmacytoma of the Head and Neck: A Report of Three Cases Treated With Curative Radiotherapy and a Review of the Dose-Control Relationship.

Irving Sanchez, David Oñate, Tania Hernandez, Victor Ruiz, Omar Diaz, Janie S Munoz, Luis H Bayardo, Alejandro Villalvazo, Emanuel Gamez, Enrique Gutierrez-Valencia

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Extramedullary Plasmacytoma of Base of Tongue: A Systematic Review.World journal of otorhinolaryngology - head and neck surgery · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Irving SanchezRadiation Oncology, Western National Medical Center, Mexican Institute of Social Security (IMSS) University Center for Health Science (CUCS) University of Guadalajara, Guadalajara, MEX.
David OñateRadiation Oncology, Western National Medical Center, Mexican Institute of Social Security (IMSS) University Center for Health Science (CUCS) University of Guadalajara, Guadalajara, MEX.
Tania HernandezRadiation Oncology, Western National Medical Center, Mexican Institute of Social Security (IMSS) University Center for Health Science (CUCS) University of Guadalajara, Guadalajara, MEX.
Victor RuizRadiation Oncology, Western National Medical Center, Mexican Institute of Social Security (IMSS) University Center for Health Science (CUCS) University of Guadalajara, Guadalajara, MEX.
Omar DiazRadiation Oncology, Western National Medical Center, Mexican Institute of Social Security (IMSS) University Center for Health Science (CUCS) University of Guadalajara, Guadalajara, MEX.
Janie S MunozSchool of Medicine, Universidad Autónoma de Guadalajara, Zapopan, MEX.
Luis H BayardoRadiation Oncology, Western National Medical Center, Mexican Institute of Social Security (IMSS) University Center for Health Science (CUCS) University of Guadalajara, Guadalajara, MEX.
Alejandro VillalvazoRadiation Oncology, Western National Medical Center, Mexican Institute of Social Security (IMSS) University Center for Health Science (CUCS) University of Guadalajara, Guadalajara, MEX.
Emanuel GamezPathology, Western National Medical Center, Mexican Institute of Social Security (IMSS) University Center for Health Science (CUCS) University of Guadalajara, Guadalajara, MEX.
Enrique Gutierrez-ValenciaRadiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, CAN.
Mexican Social Security Institute · MXPrincess Margaret Cancer Centre · CAUniversidad Autónoma de Guadalajara · MXUniversidad de Guadalajara · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solitary plasmacytoma is an uncommon hematologic malignancy characterized by the monoclonal proliferation of abnormal plasma cells in the bone or extramedullary tissues and the absence of other multiple myeloma-defining clinical characteristics. Mostly, solitary extramedullary plasmacytoma (SEP) occurs in the head and neck region, also called solitary extramedullary plasmacytoma of the head and neck (SEPHN). Although the standard of care for SEPHN is not well established, either a surgical approach or localized external beam radiotherapy (EBRT) can be used as a definitive treatment. Due to the high radiosensitivity of SEPHN, EBRT has been associated with adequate therapeutic effects in the management of SEP, with the advantage of being a noninvasive modality that yields high rates of local control with a reasonable toxicity profile. We present a case series of three patients with SEPHN treated with EBRT at our institution with clinical outcomes.

Indexed as

3-d radiotherapyhead and neck neoplasmslaryngeal neoplasmslarynx preservationmultiple myeloma treatmentnasopharyngeal neoplasmoropharyngeal neoplasmsplasma cell tumorradical radiotherapysolitary extramedullary plasmacytoma (sep)

Identifiers

PMID37288179
PMCPMC10241747
OpenAlexW4368368315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.